Trial intelligence / Profile preview

Itraconazole and Pemetrexed in Previously Treated Non-Squamous NSCLC

NCT00769600Phase 2Terminated

Sponsor
Sidney Kimmel Comprehensive Cancer Center
Start
Nov 2008
Primary completion
Jan 2013
Modality
Orthosteric Ligands
Countries
2
01

Overview

A Phase 2 trial of itraconazole in non-small cell lung cancer (NSCLC), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Nov 2008; status: terminated.

02

Drugs

itraconazole
03

Conditions

non-small cell lung cancer (NSCLC)

Beyond the preview

Go deeper on NCT00769600.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00769600.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call